Das Produkt wurde korrekt in den Warenkorb gelegt.

discount label
Ac-SLV-NH2
3D-Ansicht

Biosynth logo

Ac-SLV-NH2

Ref. 3D-PP47466

Unbestimmte GrößeNachfragen
Voraussichtliche Lieferung in Vereinigte Staaten, am Mittwoch 30. Oktober 2024

Produktinformation

Name:
Ac-SLV-NH2
Beschreibung:

Peptide Ac-SLV-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-SLV-NH2 include the following: Structure-based design and optimization of antihypertensive peptides to obtain high inhibitory potency against both renin and angiotensin I-converting enzyme Z Zhou, C Cheng, Y Li - SAR and QSAR in Environmental , 2015 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/1062936X.2015.1104725 Lung cancer-targeting peptides with multi-subtype indication for combinational drug delivery and molecular imaging YH Chi , JK Hsiao , MH Lin, C Chang, CH Lan - Theranostics, 2017 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436516/ Derivation of inhibitory peptides to target the cardiac troponin C-I interaction as potential therapeutics for heart failure Y Xu, R Huang, J Gu, W Jiang - International Journal of Peptide Research , 2017 - Springerhttps://link.springer.com/article/10.1007/s10989-017-9576-6 Renoprotective effects of combined endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 in acute and chronic experimental renal damage Y Sharkovska, P Kalk, K von Websky, K Relle - Clinical , 2011 - researchgate.nethttps://www.researchgate.net/profile/Markus-Alter-2/publication/51615440_Renoprotective_Effects_of_Combined_Endothelin-Converting_EnzymeNeutral_Endopeptidase_Inhibitor_SLV338_in_Acute_and_Chronic_Experimental_Renal_Damage/links/547354f00cf216f8cfaf3648/Renoprotective-Effects-of-Combined-Endothelin-Converting-Enzyme-Neutral-Endopeptidase-Inhibitor-SLV338-in-Acute-and-Chronic-Experimental-Renal-Damage.pdf Computational redesign of human respiratory syncytial virus epitope as therapeutic peptide vaccines against pediatric pneumonia X Shi, J Zheng, T Yan - Journal of Molecular Modeling, 2018 - Springerhttps://link.springer.com/article/10.1007/s00894-018-3613-z Preliminary analysis of the polypeptides of the salmon leukemia virus (SLV) and evidence for development of a bimodal viremia following SLV infection WD Eaton , B Folkins, ML Kent , S Dawe - Veterinary , 1994 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0378113594900205 Molecular design and optimization of hepatic cancer SLP76-derived PLCγ1 SH3-binding peptide with the systematic N-substitution of peptide PXXP motif W Tang, Z Zhao, C Wang, T Ye - Journal of Molecular , 2019 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jmr.2806 Amino acid sequence homology of mammalian type C RNA virus major internal proteins S Oroszlan, T Copeland, MR Summers - Journal of biological , 1975 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0021925819410569 Characterization of the 70 kDa polypeptide of the Na/Ca exchanger RI SABA, A Bollen, A Herchuelz - Biochemical journal, 1999 - portlandpress.comhttps://portlandpress.com/biochemj/article-abstract/338/1/139/34598 Endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 prevents hypertensive cardiac remodeling in a blood pressure-independent manner P Kalk, Y Sharkovska, E Kashina, K von Websky - , 2011 - Am Heart Assochttps://www.ahajournals.org/doi/abs/10.1161/hypertensionaha.110.163972 Dietary Copper Supplementation Enhances Vascular Function in a C57/Bl6 Mouse ML Tickner, DJ Lamb, SMO Hourani - Clinical Science, 2002 - portlandpress.comhttps://portlandpress.com/clinsci/article-abstract/103/s47/13P/105614 Real-time monitoring of interactions between Ebola fusion peptide and solid-supported phospholipid membranes: Effect of peptide concentration and layer M Khorshid , P Losada-Perez , G Wackers , D Yongabi - Physics in Medicine, 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2352451017300033 Molecular engineering of respiratory syncytial virus immunogen for rational redesign of prophylactic peptide vaccines against pediatric viral pneumonia H Ni, Y Zhuang, Z Chen, W Ji - Molecular Simulation, 2018 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/08927022.2017.1383989 Structure-based derivation of peptide inhibitors to target TGF-beta1 receptor for the suppression of hypertrophic scarring fibroblast activation H Hu, S Yang, J Zheng, G Mao - Chemical Biology & Drug , 2017 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/cbdd.12954 Total amino acids by UHPLC-UV in infant formulas and adult nutritionals, first action 2018.06 G Jaudzems, J Guthrie, S Lahrichi - Journal of AOAC , 2019 - academic.oup.comhttps://academic.oup.com/jaoac/article-abstract/102/5/1574/5658373 Computational design of peptide ligands to target the intermolecular interaction between viral envelope protein and pediatric receptor D Xu, H Bian, J Cai, D Bao, Q Jin, M Zhu - Biology and Chemistry, 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S147692711730155X Effects of cytoplasmic domain length on cell surface expression and syncytium-forming capacity of the simian immunodeficiency virus envelope glycoprotein CP Spies, RW Compans - Virology, 1994 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0042682284714498 Tuning the viscoelasticity of peptide vesicles by adjusting hydrophobic helical blocks comprising amphiphilic polypeptides CJ Kim , M Ueda , T Imai, J Sugiyama , S Kimura - Langmuir, 2017 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.langmuir.7b00289 alpha-Enolase-binding peptide enhances drug delivery efficiency and therapeutic efficacy against colorectal cancer CH Wu, YH Kuo, RL Hong, HC Wu - Science translational medicine, 2015 - science.orghttps://www.science.org/doi/abs/10.1126/scitranslmed.aaa9391 Novel therapy approach in primary stroke prevention: simultaneous inhibition of endothelin converting enzyme and neutral endopeptidase in spontaneously C Wengenmayer, M Krikov, S Mueller, K Lucht - Neurological , 2011 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1179/016164111X12881719352534 Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic rats C Thöne-Reinke, K Simon, CM Richter - Journal of , 2004 - journals.lww.comhttps://journals.lww.com/cardiovascularpharm/abstract/2004/11001/inhibition_of_both_neutral_endopeptidase_and.20.aspx Mg2+ binding promotes SLV as a scaffold in varkud satellite ribozyme SLI-SLV kissing loop junction C Bergonzo , TE Cheatham - Biophysical Journal, 2017 - cell.comhttps://www.cell.com/biophysj/pdf/S0006-3495(17)30629-X.pdf Induction of caspase-8 in human cells by the extracellular administration of peptides containing a C-terminal SLV sequence A Scheller, M Melzig , J Oehlke - Letters in Peptide Science, 2001 - Springerhttps://link.springer.com/article/10.1023/A:1014218104739 Rigorous control of vesicle-forming lipid pKa by fluorine-conjugated bioisosteres for gene-silencing with siRNA A Okamoto, H Koide, N Morita, Y Hirai, Y Kawato - Journal of controlled , 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365918307491

Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:

Chemische Eigenschaften

MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:

Gefahrenhinweise

UN-Nummer:
EQ:
Klasse:
H-Sätze:
P-Sätze:
Flugverbot:
Gefahrenhinweis:
Verpackungsgruppe:
LQ:

Technische Anfrage zu: 3D-PP47466 Ac-SLV-NH2

Bitte verwenden Sie stattdessen den Warenkorb, um ein Angebot oder eine Bestellung anzufordern

Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.

* Obligatorische felder
Willkommen bei CymitQuimica!Wir verwenden Cookies, um Ihren Besuch zu verbessern. Wir schließen Werbung nicht ein.

Bitte beachten Sie unsere Cookie-Richtlinie  für weitere Details oder passen Sie Ihre Einstellungen unter “Konfigurieren” an.